Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Cash from Investing Activities (2016 - 2025)

Adma Biologics' Cash from Investing Activities history spans 13 years, with the latest figure at -$276000.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 89.96% year-over-year to -$276000.0; the TTM value through Dec 2025 reached -$21.9 million, down 155.29%, while the annual FY2025 figure was -$21.9 million, 155.29% down from the prior year.
  • Cash from Investing Activities reached -$276000.0 in Q4 2025 per ADMA's latest filing, up from -$14.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$276000.0 in Q4 2025 to a low of -$14.4 million in Q3 2025.
  • Average Cash from Investing Activities over 5 years is -$3.1 million, with a median of -$2.7 million recorded in 2021.
  • The largest YoY upside for Cash from Investing Activities was 89.96% in 2025 against a maximum downside of 1208.56% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$3.7 million in 2021, then fell by 1.98% to -$3.7 million in 2022, then skyrocketed by 62.46% to -$1.4 million in 2023, then tumbled by 95.45% to -$2.8 million in 2024, then skyrocketed by 89.96% to -$276000.0 in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Cash from Investing Activities are -$276000.0 (Q4 2025), -$14.4 million (Q3 2025), and -$2.5 million (Q2 2025).